Ikaria® Begins Enrollment of Pivotal Trial for LUCASSIN® - PR Newswire (press release) PDF Print
PR Newswire (press release)
It is characterized by rapid onset of renal failure with a high mortality rate that exceeds 80% within three months. The REVERSE Trial will compare

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.